Rhinitis/rhinorrhea (intranasal products):
Indications for: Flunisolide Spray
Seasonal or perennial rhinitis.
≥15yrs: initially 2 sprays in each nostril twice daily; may increase to 2 sprays 3 times daily. Max 8 sprays/nostril per day.
<6yrs: not recommended. 6–14yrs: initially 1 spray in each nostril 3 times daily or 2 sprays twice daily; max 4 sprays/nostril per day.
Flunisolide Spray Contraindications:
Untreated nasal infections.
Flunisolide Spray Warnings/Precautions:
Maintain regular regimen. Respiratory tract tuberculosis. Infections (eg, ocular herpes simplex). If exposed to measles or chickenpox, consider anti-infective prophylactic therapy. Reduce dose as condition improves. May use nasal decongestants if needed. Discontinue if no effect after 3 wks. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with topical corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, depression). Monitor for growth suppression in children. Monitor for hypercorticism and HPA axis suppression (if occur discontinue gradually), and candida infection or other nasal mucosal changes. Avoid eyes. Pregnancy (Cat.C). Nursing mothers.
Flunisolide Spray Classification:
Nasal discomfort, congestion, sneezing, epistaxis, lacrimation, sore throat, nausea, headache, loss of taste and smell, septal perforation, hypercorticism, fungal overgrowth, impaired wound healing, glaucoma, reduced growth velocity in children.
Formerly known under the brand names Nasalide, Nasarel.